An app called CamAPS HX predicts how much insulin is needed to maintain glucose levels in the body
Researchers at the University of Cambridge have successfully tested an artificial pancreas that could give people with type-2 diabetes a new lease of life. It is powered by an app connected to a glucose monitor and insulin pump.
The burden of diabetes continues to rise worldwide. Estimates show that 77 million people in India are suffering from diabetes in 2019. This is expected to rise to over 134 million by 2045.
Due to the increasing number of people with diabetes and the severity of the disease, researchers at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge have developed an artificial pancreas that helps maintain healthy glucose levels.
Many people with type 2 diabetes struggle to control their blood sugar levels using currently available treatments such as insulin injections. A new strategy has been discovered to keep blood glucose levels stable.
The app, called CamAPS HX, works by developing an algorithm that predicts how much insulin is needed to maintain the body’s glucose levels in the target range. It is through this process that the artificial pancreas works.
And in early human trials, the artificial pancreas helped lower levels of a molecule called glycated hemoglobin, or HbA1c. It is formed when hemoglobin combines with glucose in the blood. As a result, the glucose level in the body of the patients is maintained at the right level, the team of researchers said.
It will be approved for public use after completion of final phase studies. And it was developed for normal use at home, the research team said.